In this video, virology professor Vincent Racaniello provides a detailed scientific analysis of the newly identified SARS-CoV-2 variant in the UK (VUI-202012/01), arguing that the widespread fear and media hype surrounding it are unwarranted. He begins by explaining the fundamental principles of virology, emphasizing that viral mutation is a constant and expected process, and that the vast majority of these mutations are neutral. He distinguishes between a "variant" (a virus with genomic changes) and a "strain" (a variant with a proven, distinct biological property), stating we have only seen variants of SARS-CoV-2. Racaniello systematically debunks the epidemiological evidence used to claim the new variant is more transmissible, arguing that observations like a rising R-value and lower PCR CT values are circumstantial and can be explained by founder effects and super-spreader events, rather than an inherent change in the virus. He criticizes the reliance on PCR data, which measures viral RNA, not infectious virus, as a flawed method for determining transmissibility. Finally, he asserts that the changes are highly unlikely to allow the virus to evade immunity from vaccines, and concludes that the focus should remain on vaccination programs rather than alarmism over variants whose properties have not been experimentally proven.
A Virologist's Take on the UK SARS-CoV-2 Variant
0:00 Introduction: No Cause for Concern: The speaker, a virology professor, addresses the fear surrounding a new SARS-CoV-2 variant in the UK and states that he is not concerned, criticizing media headlines for a lack of scientific understanding.
0:50 What is a Mutation?: A mutation is a change in the nucleic acid (RNA or DNA) of an organism. It is a natural and constant process for all viruses. Using the term to describe protein changes is incorrect; the mutation is in the genome, while the effect may be a change in a protein.
1:56 Coronaviruses Mutate Constantly: All RNA viruses mutate during replication. While coronaviruses have a proofreading mechanism that makes them mutate slower than many other RNA viruses, mutations still occur frequently. Every infected cell produces a cloud of slightly different viruses, known as a "quasi-species."
5:49 Variant vs. Strain: A "variant" has genomic differences, while a "strain" is a variant that has a proven, distinct biological property in humans (e.g., higher transmissibility or severity). The speaker argues that so far, we have only seen variants of SARS-CoV-2, not new strains.
7:13 The "Founder Effect" and Super-Spreading: The apparent rapid spread of a new variant does not necessarily mean it's more transmissible. It can be explained by:
Founder Effect: A person with a neutral, random variant happens to be the one who starts a new chain of infections.
Super-Spreader Events: Since 80% of transmissions are caused by only 10% of infected individuals, a variant carried by a super-spreader will spread rapidly by chance, creating a false impression of increased transmissibility.
9:58 The UK Variant's Specific Changes: The variant (VUI-202012/01) is defined by multiple amino acid changes in its spike protein. The most discussed change, N501Y, is located in the region that binds to the human cell receptor. Another mutation, a deletion in the ORF8 protein, has previously been associated with less severe disease.
15:46 Debunking the Evidence for Higher Transmissibility: The speaker critiques the UK's NERVTAG committee report, which concluded the variant is more transmissible based on three flawed pieces of evidence:
Increased R-value: This is a correlation, not causation. It cannot prove a biological property of the virus.
Lower PCR CT values/Higher Viral Load: This is the most flawed argument. PCR measures the amount of viral RNA, not the amount of infectious virus. A lower CT value doesn't prove the person is shedding more transmissible virus.
18:28 Conclusion on Transmissibility: The speaker states he has "low confidence" that the variant has a substantial increase in transmissibility, as the evidence is circumstantial and not based on the right experiments.
20:12 Vaccines Will Still Work: The spike protein has around 20 different sites (epitopes) that our immune system targets. A change in one or two of these sites is highly unlikely to allow the virus to escape the broad immune response generated by vaccination or natural infection.
22:06 The Right Experiments Haven't Been Done: To prove a variant is more transmissible, scientists must directly measure and compare the amount of infectious virus shed from people infected with the new variant versus old variants. This has not been done.
23:50 Final Takeaway: The hype about this variant is unwarranted. While it should be studied, the public should not be alarmed. The real path out of the pandemic is to focus on and proceed with vaccination programs.